Clarus Therapeutics Holdings (Clarus Therapeutics Holdings) FCF Yield % : -77,582.19 (As of Jun. 25, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Clarus Therapeutics Holdings FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Clarus Therapeutics Holdings's Trailing 12-Month Free Cash Flow is $0.00 Mil, and Market Cap is $0.00 Mil. Therefore, Clarus Therapeutics Holdings's FCF Yield % for today is -77,582.19%.

The historical rank and industry rank for Clarus Therapeutics Holdings's FCF Yield % or its related term are showing as below:

CRXWQ' s FCF Yield % Range Over the Past 10 Years
Min: -128049.47 Med: -478.35 Max: -14.56
Current: -77582.19

During the past 2 years, the highest FCF Yield % of Clarus Therapeutics Holdings was -14.56%. The lowest was -128049.47%. And the median was -478.35%.

CRXWQ's FCF Yield % is not ranked
in the Drug Manufacturers industry.
Industry Median: -0.16 vs CRXWQ: -77582.19

Clarus Therapeutics Holdings's FCF Margin % for the quarter that ended in Jun. 2022 was -432.12%.

Clarus Therapeutics Holdings FCF Yield % Historical Data

The historical data trend for Clarus Therapeutics Holdings's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clarus Therapeutics Holdings FCF Yield % Chart

Clarus Therapeutics Holdings Annual Data

Trend

Dec20

Dec21

FCF Yield %

Clarus Therapeutics Holdings Quarterly Data
	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22
FCF Yield %	Get a 7-Day Free Trial			-	-	-	-	-

Competitive Comparison of Clarus Therapeutics Holdings's FCF Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, Clarus Therapeutics Holdings's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Clarus Therapeutics Holdings's FCF Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Clarus Therapeutics Holdings's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Clarus Therapeutics Holdings's FCF Yield % falls into.

Clarus Therapeutics Holdings FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Clarus Therapeutics Holdings's FCF Yield % for the fiscal year that ended in Dec. 2021 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-43.811	/
	=	N/A%

Clarus Therapeutics Holdings's annualized FCF Yield % for the quarter that ended in Jun. 2022 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-17.501	*	4	/
	=	N/A%

Clarus Therapeutics Holdings FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Clarus Therapeutics Holdings FCF Yield % Related Terms

Thank you for viewing the detailed overview of Clarus Therapeutics Holdings's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Clarus Therapeutics Holdings (Clarus Therapeutics Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Clarus Therapeutics Holdings Inc (OTCPK:CRXWQ) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

555 Skokie Boulevard, Suite 340, Northbrook, IL, USA, 60062

Website

https://www.clarustherapeutics.com

Clarus Therapeutics Holdings Inc is a pharmaceutical company with expertise in developing androgen and metabolic therapies for men and women, including potential therapies for orphan indications. The company is focused on focused on the commercialization of JATENZO (testosterone undecanoate), the first and only oral testosterone replacement, or testosterone replacement therapy, and JATENZO is the sole source of company's revenue.